(Q36602561)

15 August 2017

1 reference

title

Basal-like breast cancer and the BRCA1 phenotype (English)

1 reference

15 August 2017

1 reference

1 reference

Turner NC

1

1 reference

PubMed ID

16998499

15 August 2017

Reis-Filho JS

series ordinal

2

1 reference

PubMed ID

16998499

15 August 2017

language of work or name

English

0 references

publication date

1 September 2006

1 reference

15 August 2017

1 reference

15 August 2017

25

1 reference

15 August 2017

5846-5853

1 reference

15 August 2017

43

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1209876

15 August 2017

0 references

cites work

High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Molecular classification and molecular forecasting of breast cancer: ready for clinical application?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 methylation: a significant role in tumour development?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Gene expression profiling of breast cell lines identifies potential new basal markers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Genetic and Histopathologic Evaluation ofBRCA1andBRCA2DNA Sequence Variants of Unknown Clinical Significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Monoclonal marker that predicts early recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 Inhibition of Estrogen Receptor Signaling in Transfected Cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 functions as a breast stem cell regulator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The prognostic implication of the basal-like (cyclin E high/p27 low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 supports XIST RNA concentration on the inactive X chromosome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Gene-Expression Profiles in Hereditary Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The biology of caveolae: lessons from caveolin knockout mice and implications for human disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The molecular pathology of hereditary breast cancer: genetic testing and therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Histopathology of BRCA1- and BRCA2-associated breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer DifferentiateBRCA2-Associated Tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The molecular portraits of breast tumors are conserved across microarray platforms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Patterns of chromosomal alterations in breast ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Promotion of mammary cancer development by tamoxifen in a mouse model of Brca1-mutation-related breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Cytogenetic alterations and cytokeratin expression patterns in breast cancer: integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Stable 'portrait' of breast tumors during progression: data from biology, pathology and genetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Molecular pathology of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Profiling familial breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 participates in DNA decatenation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Biological and prognostic significance of stratified epithelial cytokeratins in infiltrating ductal breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Distinct Genetic and Epigenetic Changes in Medullary Breast Cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

EGFR amplification and lack of activating mutations in metaplastic breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Metaplastic breast carcinomas are basal-like tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The molecular genetics of breast cancer: the contribution of comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

The impact of expression profiling on prognostic and predictive testing in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

X chromosomal abnormalities in basal-like human breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Breast cancer molecular subtypes respond differently to preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Generation of a functional mammary gland from a single stem cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissue

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Molecular evolution of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Stem cells and breast cancer: A field in transit

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Repeated observation of breast tumor subtypes in independent gene expression data sets

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Breast cancer classification and prognosis based on gene expression profiles from a population-based study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Purification and unique properties of mammary epithelial stem cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Somatic genetic alterations inBRCA2-associated and sporadic male breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Hallmarks of 'BRCAness' in sporadic cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Caveolin-1 in oncogenic transformation, cancer, and metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209876

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209876

1 reference

15 August 2017

1 reference

PubMed ID

16998499